VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience ... pipeline programs and key milestones for 2025.
Program Updates and Anticipated Milestones Phase 3 azetukalner clinical ... About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical ...
Program Updates and Anticipated Milestones About Azetukalner Phase ... About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company ...
Jan. 23, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company ... including multi-family homes and small commercial projects. The program’s goal is to ...
2025 promises to be a milestone-rich year ... the first potential treatment to emerge from the joint research program. Under an amended collaboration agreement, Vertex now leads global development ...
Detailed price information for Xenon Pharmaceuticals Inc (XENE-Q) from The Globe and Mail including charting and trades.
RAC is Aegis’ first payload to the moon’s surface, and it will operate for 14 days. For Stephanie Murphy, who took over the ...
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...
The combined value of all investment products tracking the NDX® ecosystem globally exceeds $500 billion94 Exchange Traded Products track NDX® in ...
LONDON, Ontario, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR ...
Jan. 30, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY), the leading U.S ... These results as well as business and philanthropic milestones underscore the company's strong business ...
Our program with Nasdaq Private Market represents a strategic step in supporting our shareholders with a liquidity option during a hyper-growth phase of the company,” said John Acunto, Co-Founder and ...